Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.
Unauthorized health product "Blow" may pose serious health risks
- Starting date:
- January 16, 2017
- Type of communication:
- Source of recall:
- Health Canada
- Identification number:
- Products affected
- What you should do
- Who is affected
- Media enquiries
- Public enquiries
- What Health Canada is doing
Health Canada is advising Canadians that it has seized the unauthorized health product “Blow,” by Limitless Pharma, from Atomik Nutrition at 450 Boulevard de Mortagne, Boucherville, QC.
“Blow” is promoted as a pre-workout supplement and is labelled to contain the unauthorized drug 1,3 Dimethylamylamine (DMAA), which may pose serious health risks such as high blood pressure and stroke.
"Blow," by Limitless Pharma.
What you should do
- Stop using this product. Consult with your health care professional if you have used this product and have health concerns.
- Read product labels to verify that health products have been authorized for sale by Health Canada. Authorized health products have an eight-digit DIN, DIN-HM or NPN. You can also check if products have been authorized for sale by searching Health Canada’s Drug Product Database and Licensed Natural Health Product Database.
- Report adverse events to health products to Health Canada by calling toll-free at 1‑866‑234‑2345, or by reporting online, by mail or by fax.
- Report complaints about health products to Health Canada by calling toll-free at 1‑800‑267‑9675, or complete an online complaint form.
Who is affected
Consumers who have bought or used this product.
1,3-Dimethylamylamine (DMAA) is a drug that is not authorized for use in Canada. Side effects include high blood pressure, shortness of breath, chest pain, stroke and psychiatric disorders.
What Health Canada is doing
Health Canada seized the product from the retail location after receiving a consumer complaint. Should additional retailers or distributors be identified, Health Canada will take appropriate action and inform Canadians.
Select thumbnail to enlarge - opens in a new window
- Date modified: